CoV-2’s origin continue to circulate, further complicating efforts to maintain a constructive, evidence-based public ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

FRIDAY, May 9, 2025 (HealthDay News) -- mRNA-1083 vaccine is noninferior and induces higher immune responses than recommended ...

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...

Novavax (NasdaqGS:NVAX) recently amended its collaboration agreement with Takeda, enhancing its revenue potential through a new upfront payment structure and future royalties. These developments, ...

SARS-CoV-2 uses M Pro to trim viral proteins into usable parts, which the virus then uses to replicate in human cells. Viral proteases have often been the target of attempts to make antiviral ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...

Last week, the website covid.gov looked very different, containing information on coping with covid and US research. This week it leads you to a White House webpage outlining the lab-leak ...